The Korea Health Industry Development Institute (KHIDI) and AstraZeneca Korea have jointly supported the entry of leading Korean pharmaceutical and biotechnology companies into the Chinese market through the "K-Bio Expressway Project," which took place from April 22 to 26.The project stems from a me
AstraZeneca is an England-based biopharmaceutical company that researches and develops prescription medicines for the treatment of cancer and renal diseases.